It was reported to boston scientific corporation that an orbera365 intragastric balloon system was implanted into the patient on (b)(6) 2023.After approximately 10 months, the patient reported weight gain and bluish urine.On (b)(6) 2024, an endoscopic procedure was performed and confirmed the balloon was largely deflated.The balloon was explanted.There were no patient complications as a result of this event.Note: it was reportable that methylene blue was used when filling the orbera balloon.However, according to the instructions for use (ifu), "the igb is placed in the stomach and filled with sterile saline.".
|